BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin
Year: 2005
Type: article
Source: Oncogene
Language: English
Topic: DNA Repair Mechanisms
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2083399846
